SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-307131
Filing Date
2017-10-10
Accepted
2017-10-10 16:34:03
Documents
3
Period of Report
2017-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d469559d8k.htm 8-K 18870
2 EX-10.1 d469559dex101.htm EX-10.1 118922
3 EX-99.1 d469559dex991.htm EX-99.1 8915
  Complete submission text file 0001193125-17-307131.txt   147849
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 171130842
SIC: 2834 Pharmaceutical Preparations